000 01477 a2200433 4500
005 20250515205712.0
264 0 _c20100913
008 201009s 0 0 eng d
022 _a1432-1335
024 7 _a10.1007/s00432-010-0819-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYing, Mingzhen
245 0 0 _aLoss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma.
_h[electronic resource]
260 _bJournal of cancer research and clinical oncology
_cOct 2010
300 _a1617-26 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBreast Neoplasms
_xchemistry
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphatic Metastasis
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xetiology
650 0 4 _aPhosphorylation
650 0 4 _aPrognosis
650 0 4 _aSTAT3 Transcription Factor
_xmetabolism
650 0 4 _aSuppressor of Cytokine Signaling 3 Protein
650 0 4 _aSuppressor of Cytokine Signaling Proteins
_xanalysis
700 1 _aLi, Dawei
700 1 _aYang, Linjun
700 1 _aWang, Mei
700 1 _aWang, Ning
700 1 _aChen, Ying
700 1 _aHe, Miaoxia
700 1 _aWang, Yajie
773 0 _tJournal of cancer research and clinical oncology
_gvol. 136
_gno. 10
_gp. 1617-26
856 4 0 _uhttps://doi.org/10.1007/s00432-010-0819-6
_zAvailable from publisher's website
999 _c19525676
_d19525676